Following the success of Everybody Loves Raymond: 30th Anniversary Special Reunion special, CBS is doing a followup. The hourlong Everybody Loves Raymond: 30th Anniversary Special Reunion Pt. 2 will ...
Will the A-list star face off against Robert Pattinson? A new report has cleared the air regarding Brad Pitt’s rumored villain role in ‘The Batman Part II’. Brad Pitt will not appear as a villain in ...
Netflix has announced a release date for the new season of Tyler Perry's "Beauty in Black," meaning that more Bellaire business and drama is coming at the top of 2026. The power struggle continues as ...
Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...
Scarlett Johansson could be making the jump to DC, as the former Marvel Cinematic Universe (MCU) star is reportedly in talks to join The Batman Part 2. News about the superhero switch-up, which ...
Salt Lake City, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company decoding biology to radically improve lives, announced today that it will present a ...
We're more than a little obsessed with Stranger Things, and while we're sad we've reached the final season we are sooo excited to see how the show will come to an end. Season five, part one dropped ...
Recursion Pharmaceuticals' work could change the way that drugs are developed. Its pipeline features some exciting candidates, and it's partnering with major drugmakers. However, Recursion still needs ...
From left: Ariana Grande (Glinda), Cynthia Erivo (Elphaba), Michelle Yeoh (Madame Morrible) and Jeff Goldblum (the Wizard). (Universal Pictures/Courtesy Everett Collection) Director Jon M. Chu first ...
Shraddha Kapoor is stepping into the world of animation as the Hindi voice of Judy Hopps in Disney’s upcoming 'Zootopia 2'. Walt Disney Studios India announces the casting with a promotional poster ...
After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...
Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stock is surging on Wednesday, without any news to justify the movement. Session volume stands at 69.3 million versus the average volume of 26.9 million, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback